DIVISION OF HEMATOLOGY-ONCOLOGY

Clinical Programs

Oncology

We are members of the Children's Oncology Group, a national consortium of institutions dedicated to curing cancer in children and adolescents by offering state-of-the-art therapy in the form of clinical trials. We provide comprehensive assessment and treatment in a multidisciplinary fashion in specialized programs:

  • Leukemia & Lymphoma Program
  • Bone & solid tumor Program
  • Neuro-Oncology Program
  • Cancer Genetics and Risk Assessment

Furthermore, the Division holds a federal grant for the South Texas Pediatric Minority Based CCOP, a consortium of four institutions whose mission is to facilitate access to COG clinical trials for minority children and adolescents affected by cancer.


Childhood Cancer Survivors Program

Cancers considered incurable thirty years ago, now respond to treatments that produce 80% overall survival. The program provides comprehensive care and support for cancer survivors and their families. Our philosophy is that survivors of childhood cancer should be seen once a year, followed for life and well-informed about their health history.


Hematology

Our hematology program encompasses bleeding and thrombotic disorders, sickle cell disease, and a wide variety of hematological disorders.


South Texas Comprehensive Hemophilia & Thrombophilia Treatment Center

STCHTTC is a federally funded program focusing on the evaluation, treatment, and prevention of complications from:

  • Hemophilia
  • Von Willebrand's Disease
  • Thrombophilia
  • Menorrhagia in adolescents & women

Children's Regional Sickle Cell Center

The children's Regional Sickle Cell Center is dedicated to the prevention of complications in patients affected with sickle cell disease.

  • Confirmation of abnormal hemoglobin found on newborn screening
  • Education about pain management and infectious complications
  • Transcranial Doppler to identify patients at risk of stroke
  • Erthrocytopheresis to decrease the risk of iron overload to transfusions